Comparer des méthodes
Examinez les méthodes sélectionnées côte à côte ; les lignes qui diffèrent sont mises en évidence.
| Modèle conjoint pour données longitudinales et données de temps d'événement× | Analyse de jalon pour la survie conditionnelle et la prédiction dynamique× | |
|---|---|---|
| Domaine | Analyse de survie | Analyse de survie |
| Famille | Survival analysis | Survival analysis |
| Année d'origine≠ | 2004 | 1983 |
| Auteur d'origine≠ | Tsiatis, A.A. & Davidian, M.; Rizopoulos, D. | Anderson, J. R., Cain, K. C. & Gelber, R. D. |
| Type≠ | Semiparametric regression model | Conditional survival estimator |
| Source fondatrice≠ | Rizopoulos, D. (2012). Joint Models for Longitudinal and Time-to-Event Data. CRC Press. DOI ↗ | Anderson, J. R., Cain, K. C. & Gelber, R. D. (1983). Analysis of Survival by Tumor Response. Journal of Clinical Oncology, 1(11), 710–719. DOI ↗ |
| Alias | joint model, shared random effects model, longitudinal-survival joint model, Joint Model (Boylamsal + Sağkalım Birleşik Model) | landmark method, dynamic prediction, conditional survival estimation, Landmark Analizi (Dinamik Tahmin) |
| Apparentées≠ | 5 | 3 |
| Résumé≠ | The joint model for longitudinal and time-to-event data, formalised by Tsiatis and Davidian in 2004 and extended comprehensively by Rizopoulos in 2012, simultaneously estimates a mixed-effects model for repeatedly measured biomarkers and a survival model for the time to an event, linking the two processes through shared random effects. It resolves two major problems that simpler approaches cannot handle: informative dropout from longitudinal studies and the endogeneity of time-varying biomarkers used as covariates in a Cox model. | Landmark analysis, introduced by Anderson, Cain, and Gelber in 1983, estimates conditional survival probabilities for subjects who are still at risk at a pre-specified point in time — the landmark — rather than at study entry. It was developed explicitly to avoid immortal time bias that arises when subjects are grouped by an event (such as a treatment change or biomarker result) that can only occur if they remain event-free long enough to experience it. |
| ScholarGateJeu de données ↗ |
|
|